Alpha-ray missile therapy: Tumor cells attacked from intracellular region

BMJ columnist among doctors receiving New Year honour
4 January 2021
Public health officials in Chicago take data-driven approach to reopening city public schools
4 January 2021

Alpha-ray missile therapy: Tumor cells attacked from intracellular region

A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.

Comments are closed.